ClinicalTrials.govpublic full text
Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome
nephrotic syndrome, hyperlipidemia
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 245435
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.